TDOC Stock: Price, Earnings History and SEC Filings
Teladoc Health, Inc. (TDOC) last traded at $8.51, down 2.52% on the latest session and up 46.7% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $-0.15 against an analyst estimate of $-0.23, a beat of 34.8%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
TDOC earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $-0.15 | $-0.23 | +34.78% |
| Jun 2026 | Jul 29, 2026 | $-0.21 | $-0.24 | +12.50% |
| Mar 2026 | Apr 29, 2026 | $-0.36 | $-0.32 | -12.50% |
| Dec 2025 | Feb 25, 2026 | $-0.14 | $-0.19 | +26.32% |
TDOC beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How TDOC reacts to earnings
Across its last 8 earnings releases, TDOC moved 11.6% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-28 | After close | +26.89% |
| 2026-07-29 | After close | -28.32% |
| 2026-04-29 | After close | +1.85% |
| 2026-02-25 | After close | +15.05% |
| 2025-10-29 | After close | +6.20% |
| 2025-10-23 | After close | +10.00% |
| 2025-07-29 | After close | -1.73% |
| 2025-04-30 | After close | -2.78% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
TDOC financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $2.5B | -$200M | $285M | -7.9% | $-1.14 |
| 2024 | $2.6B | -$1.0B | $283M | -39.0% | $-5.87 |
| 2023 | $2.6B | -$220M | $339M | -8.5% | $-1.34 |
| 2022 | $2.4B | -$13.7B | $173M | -567.5% | $-84.60 |
| 2021 | $2.0B | -$429M | $185M | -21.1% | $-2.73 |
| 2020 | $1.1B | -$485M | -$58M | -44.3% | $-5.36 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for TDOC
- 10-Q · Oct 29, 2026
- 8-K · Oct 28, 2026Results of operations, Financial statements and exhibits
- 8-K · Sep 25, 2026Officer or director change
- 8-K · Aug 31, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 13, 2026Officer or director change
- 8-K · Aug 3, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 10-Q · Jul 30, 2026
- 8-K · Jul 29, 2026Results of operations, Financial statements and exhibits
- 8-K · May 21, 2026Shareholder vote
- 10-Q · Apr 30, 2026
Insider filing activity
TDOC insiders filed 9 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
TDOC news
- Teladoc’s Q3 earnings call: our top 5 analyst questionsOct 31, 2026 · finance.yahoo.com
- Stocks making big moves this week: Watsco, Universal Display, Chipotle, Teladoc, and ServiceNowOct 31, 2026 · finance.yahoo.com
- Teladoc Health (TDOC) Stock Rebounds On Q3 Results As Cash Flow ImprovesOct 30, 2026 · finance.yahoo.com
- Teladoc Soars 11% on Q3 Beat and Raised Outlook as “Insurance Revenue Exceeded Our Expectations”Oct 29, 2026 · tikr.com
- Teladoc (TDOC) stock trades up, here is whyOct 29, 2026 · finance.yahoo.com
- Teladoc Health, Inc. Q3 2026 Earnings Call SummaryOct 29, 2026 · app.moby.co
- Teladoc Health Q3 Earnings Call HighlightsOct 29, 2026 · marketbeat.com
- Teladoc: 3 Key Takeaways for Long-Term InvestorsOct 29, 2026 · fool.com
About Teladoc Health, Inc.
Teladoc Health, Inc. (TDOC) is a US-listed public company on NYSE. The SEC classifies its business as Services-offices & Clinics of Doctors of Medicine. It is incorporated in DE. Its fiscal year ends in December.